[The effect of semax and mexidol on the course of acute pancreatitis in rats].
Ivanov. Iu V IuV; Iasnetsov. V V VV
Key Findings
- A single dose of semax reduced mortality in rats with acute pancreatitis to about 10‑13%.
- Semax lowered markers of inflammation, oxidative stress, and blood‑vessel leakage, and improved microcirculation in the pancreas.
- Healing of pancreatic tissue was faster and showed less scar‑like (fibrous) changes compared with control drugs.
Practical Outcomes
- For biohackers, this study suggests semax might have organ‑protective, anti‑inflammatory properties, but the evidence is limited to rats and uses injection methods not practical for everyday use. No human dosing or safety data are available, so it cannot be recommended as a self‑experiment protocol for pancreas health or general longevity at this time.
Summary
In a rat study, giving the peptide semax (or the drug mexidol) after the pancreas was damaged sharply lowered death rates and helped the organ heal faster. The benefits were seen when the drug was injected directly into the pancreas or into the belly cavity, and semax performed better than several other drugs tested.
Abstract
The effect of semax and mexidol on the course of acute pancreatitis in rats was studied in comparison with the action of contrical, fluorouracil, and dibunol. It was established that a single intraductal or intraperitoneal administration of semax or mexidol markedly reduces the loss of experimental animals (to 10-13%), decreases hyperfermentemia, lipid peroxidation activation, and vascular permeability, improves microcirculation, and accelerates healing of the damaged pancreatic zones by substitutional repair of pancreatic acini not accompanied by coarse fibrous changes in the parenchyma. Upon the intraductal administration, semax and mexidol were more effective than contrical, fluorouracil, and dibunol.
Study Information
pubmed
2000